Katharine E. Spink, Chief Operating Officer at Asterias Biotherapeutics, Inc. (AST), sold 2,500 shares at $5.00 ($13K) on 2016-11-17, disclosed to the SEC on 2016-11-21.
Scheduled sale ($12k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AST | SELL | 2016-11-28 | $14K | — | Filing → |
| AST | SELL | 2016-10-11 | $39K | — | Filing → |
| AST | SELL | 2016-09-12 | $68K | — | Filing → |